An unsatisfactory quarter for Reckitt Benckiser, reporting one of the weakest underlying sales performances in recent times (lfl growth of 2% vs. consensus estimate of 2.8%; 4% in Q2 16 and 7% in Q3 15). This was even below its closest peers – Unilever recorded 3.2% underlying growth while P&G grew by 3% during the same quarter. The major disappointment stemmed from the waning Health segment while contraction in Home and Portfolio aggravated the woes further. However, Hygiene’
02 Jan 2017
A not so ‘Healthy’ Q3
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A not so ‘Healthy’ Q3
Reckitt Benckiser Group plc (RKT:LON) | 4,521 3345.5 1.7% | Mkt Cap: 32,030m
- Published:
02 Jan 2017 -
Author:
Jyoti Prakash -
Pages:
3
An unsatisfactory quarter for Reckitt Benckiser, reporting one of the weakest underlying sales performances in recent times (lfl growth of 2% vs. consensus estimate of 2.8%; 4% in Q2 16 and 7% in Q3 15). This was even below its closest peers – Unilever recorded 3.2% underlying growth while P&G grew by 3% during the same quarter. The major disappointment stemmed from the waning Health segment while contraction in Home and Portfolio aggravated the woes further. However, Hygiene’